A national examination of disease prevalence among Medicaid beneficiaries underscores ways that managed care plans can rethink care management approaches for high-need, high-cost beneficiaries with multiple chronic conditions.
Data from The Faces of Medicaid II, a recent Center for Health Care Strategies Inc. (CHCS) study, show that beneficiaries with three or more chronic conditions are responsible for a significant portion of Medicaid spending.
"By clearly identifying and prioritizing the complex needs of beneficiaries with comorbidities, health plans can develop coordinated care interventions and integrated delivery systems that incorporate clinical care with behavioral and non-medical supportive services," says Melanie Bella, senior vice president, CHCS, and co-author of the study.
"Many Medicaid beneficiaries with multiple chronic conditions and complex, high-cost healthcare needs remain in the fragmented fee-for-service system," Bella says. "As states increasingly seek ways to better manage the care of high-need beneficiaries, managed care executives can respond by designing and testing new tailored care models that more effectively coordinate the primary, acute, behavioral, social and long-term care needs of this population."
The report cites Washington State, for example. "The state contracts with Molina Healthcare of Washington to provide health risk assessments, develop patient care plans, link multiple providers/care managers, and coordinate services," Bella explains. "A care coordinator on the patient care team plays a key role in prioritizing and directing critical resources for beneficiaries with multiple chronic conditions and behavioral health needs. The program has achieved reductions in inpatient admissions and days in state mental hospital facilities and increases in patient satisfaction."
Like Molina, other plans can recognize the opportunity to improve care for this high-need, high-cost beneficiary population, notes Bella.
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Extending the Capabilities of the EHR Through Automation
August 2nd 2023Welcome back to another episode of "Tuning In to the C-Suite," where Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of chatting with Cindy Gaines, chief clinical transformation officer at Lumeon.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More